Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Graham

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
BMC Nephrology|June 30, 2023
Comparison of two ferritin assay platforms to assess their level of agreement in measuring serum and plasma ferritin levels in patients with chronic kidney diseaseSandawana William Majoni, Jane Nelson, Jessica Graham, et al.
Biotechnology and Bioengineering|January 10, 2026
Assessment and Control of Host Cell Proteins in Biologics: Survey of Industry Practices and a Vision for HarmonizationJessica Graham, Sathanandam S Anand, Joel Bercu, et al.
Critical Reviews in Toxicology|June 15, 2022
Framework for sensitization assessment of extractables and leachables in pharmaceuticalsPatricia Parris, Geraldine Whelan, Anders Burild, et al.
Regulatory Toxicology and Pharmacology : RTP|August 14, 2022
Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acidsRobert A Jolly, Suren Bandara, Joel Bercu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 27, 2021
Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI StudySidhant Chopra, Alex Fornito, Shona M Francey, et al.
Early Intervention in Psychiatry|July 20, 2018
Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participantsBrian O'Donoghue, Shona M Francey, Barnaby Nelson, et al.
JAMA Psychiatry|June 23, 2021
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical TrialSidhant Chopra, Shona M Francey, Brian O'Donoghue, et al.
Schizophrenia Research. Cognition|March 4, 2021
Cognitive ability and metabolic physical health in first-episode psychosisSarah Whitson, Brian O'Donoghue, Robert Hester, et al.
PDA Journal of Pharmaceutical Science and Technology|September 15, 2023
Sensitization Assessment of Extractables and Leachables in Pharmaceuticals: ELSIE Database AnalysisPatricia Parris, Geraldine Whelan, Anders Burild, et al.
Translational Psychiatry|April 18, 2023
Gradients of striatal function in antipsychotic-free first-episode psychosis and schizotypyMarianne Oldehinkel, Jeggan Tiego, Kristina Sabaroedin, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
BMC Nephrology|June 30, 2023
Comparison of two ferritin assay platforms to assess their level of agreement in measuring serum and plasma ferritin levels in patients with chronic kidney diseaseSandawana William Majoni, Jane Nelson, Jessica Graham, et al.
Biotechnology and Bioengineering|January 10, 2026
Assessment and Control of Host Cell Proteins in Biologics: Survey of Industry Practices and a Vision for HarmonizationJessica Graham, Sathanandam S Anand, Joel Bercu, et al.
Critical Reviews in Toxicology|June 15, 2022
Framework for sensitization assessment of extractables and leachables in pharmaceuticalsPatricia Parris, Geraldine Whelan, Anders Burild, et al.
Regulatory Toxicology and Pharmacology : RTP|August 14, 2022
Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acidsRobert A Jolly, Suren Bandara, Joel Bercu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 27, 2021
Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI StudySidhant Chopra, Alex Fornito, Shona M Francey, et al.
Early Intervention in Psychiatry|July 20, 2018
Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participantsBrian O'Donoghue, Shona M Francey, Barnaby Nelson, et al.
JAMA Psychiatry|June 23, 2021
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical TrialSidhant Chopra, Shona M Francey, Brian O'Donoghue, et al.
Schizophrenia Research. Cognition|March 4, 2021
Cognitive ability and metabolic physical health in first-episode psychosisSarah Whitson, Brian O'Donoghue, Robert Hester, et al.
PDA Journal of Pharmaceutical Science and Technology|September 15, 2023
Sensitization Assessment of Extractables and Leachables in Pharmaceuticals: ELSIE Database AnalysisPatricia Parris, Geraldine Whelan, Anders Burild, et al.
Translational Psychiatry|April 18, 2023
Gradients of striatal function in antipsychotic-free first-episode psychosis and schizotypyMarianne Oldehinkel, Jeggan Tiego, Kristina Sabaroedin, et al.
Pageof 6